(2026). Combined administration of interleukin-2 and 18 with anti-PD-L1 antibody induces CCL5-positive CD8 T cells to suppress liver tumors. PNAS Nexus.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Combined Administration of Interleukin-2 and 18 with Anti-PD-L1 Antibody Induces CCL5-positive CD8 T Cells to Suppress Liver Tumors."
PNAS Nexus 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Combined Administration of Interleukin-2 and 18 with Anti-PD-L1 Antibody Induces CCL5-positive CD8 T Cells to Suppress Liver Tumors."
PNAS Nexus, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.